BioCina: Funding, Investors & Team (Sep 2026)
BioCina Pty Ltd. is a multi-product biologics contract development and manufacturing organization (CDMO), focused on the development and cGMP manufacture of microbial-based biological pharmaceuticals, including proteins, pDNA, mRNA, vaccines and biosimilars, from early development through to commercialization. The BioCina Adelaide facility, formerly the Pfizer/Hospira plant, has a physical footprint of almost 60,000 ft2 for GMP manufacturing, process development, warehouse, and administration.
BioCina has raised $5.6M across 2 funding rounds on record, the most recent an undisclosed round of $3.3M announced in Apr 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioCina Company Profile and Key Stats
Latest funding round on record: Apr 2023.
BioCina Funding Rounds
BioCina raised $2.3M in a Grant announced in Apr 2022.
1 years later, an undisclosed round of $3.3M was announced in Apr 2023.
BioCina Founders and Leadership Team
Contact details for the BioCina team: 1 of 1 has an email address on file.
Start 14-day free trial →BioCina Funding Compared to Other Biotechnology Startups
BioCina's latest round of $3.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioCina in Biotechnology and Thebarton
Companies Similar to BioCina
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
BioCina Funding FAQs
What does BioCina do?
BioCina Pty Ltd. is a multi-product biologics contract development and manufacturing organization (CDMO), focused on the development and cGMP manufacture of microbial-based biological pharmaceuticals, including proteins, pDNA, mRNA, vaccines and biosimilars, from early development through to commercialization. The BioCina Adelaide facility, formerly the Pfizer/Hospira plant, has a physical footprint of almost 60,000 ft2 for GMP manufacturing, process development, warehouse, and administration.
How much funding has BioCina raised?
BioCina has raised $5.6M across 2 rounds on record. The most recent is an undisclosed round of $3.3M announced in Apr 2023.
When did BioCina last raise funding?
BioCina's most recent funding round on record is an undisclosed round of $3.3M, announced in Apr 2023.
Who founded BioCina?
FundedIQ lists Ian Wisenberg (Founder) at BioCina.
Where is BioCina headquartered?
BioCina is based in Thebarton, South Australia, Australia.
How many employees does BioCina have?
BioCina is in the 101-250 employee band.
How does BioCina's funding compare to other Biotechnology startups?
BioCina's latest round of $3.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BioCina Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioCina is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.